Tessella. Complex problems. Solved.

Posts Tagged ‘drug-development’

On Demand Webinar: FDA guidance on adaptive design – what does it means for you?

Tuesday, June 22nd, 2010

In Feb 2010 the FDA issued a draft guidance for industry on “Adaptive Design Clinical Trials for Drugs and Biologics” (pdf). Join Tom Parke in this on-demand webinar as he quizzes adaptive trial gurus Prof Don Berry and Dr Scott Berry on the implications of the FDA Guidance. Tom will be getting answers to the key [...]

Webinar 8th June: FDA guidance on adaptive design – what does it mean for you?

Wednesday, May 12th, 2010

Register for our live webcast on Tuesday, 8 June 2010 08:00 (PDT) 11:00 (EDT) 16:00 (BST)  17:00 (CEST) Join Tom Parke as he quizzes adaptive trial gurus Prof. Don Berry and Dr. Scott Berry on the implications of the recent FDA Guidance on Adaptive Design for Clinical Trials. Tom will be getting answers to the key [...]

11th Annual Drug Discovery Leaders Summit, June 9-10th, 2010, Montreux, Switzerland

Wednesday, May 12th, 2010

Tessella are proudly sponsoring the 11th Annual Drug Discovery Leaders Summit taking place on June 9-10th, 2010 in Montreux, Switzerland. Over 2 days, the comprehensive and scientific conference programme will feature key note addresses, case study presentations, panel and roundtable discussions of over 45 senior level industry speakers from leading pharmaceutical, biotechnology organisations as well [...]

Bio Research Online: Tom Parke Unveils Prototype Version Of Combination Finder Trial Design Software At CHI’s Combination Therapies Conference

Recently, Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments previewed clinical trial design software that addresses the challenge of designing Phase 1 trials for combination therapies…read more

PRESS RELEASE: US preview for Tessella’s combination therapies trial design software

Tom Parke unveils prototype version of combination finder trial design software at CHI’s combination therapies conference. Oxford, UK | 14 April 2010. Today, Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments previewed clinical trial design software that addresses the challenge of designing Phase 1 trials [...]

New Scientist: Personalised cancer trial promises better drugs faster

Friday, March 19th, 2010

Major changes to the way cancer drugs are tested in people could lead to better and cheaper therapies coming to the market more quickly…read more

Bio-IT Best Practice Awards 2010, April 21, World Trade Centre, Boston, MA, USA

Wednesday, February 17th, 2010

Once again, Tessella is proudly sponsoring this years’ Bio-IT Best Practice Awards 2010, being held at the World Trade Centre, Boston, MA, USA on April 21, 2010 in conjunction with Bio-IT’s World Conference and Expo 2010. Established in 2003, the award programme recognizes teams in industry and academia for their outstanding innovations and excellence in the [...]

Tessella and Berry Consultants team to deliver smarter clinical trials

Tuesday, February 9th, 2010

Faced with the challenge of falling success rates in drug development, clinical development teams must find new ways forward. Tessella and Berry Consultants believe that designing smarter clinical trials is part of the solution. We believe that better trial design can help: • Maximize the impact of your clinical trials on your drug development process. [...]

I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Friday, January 8th, 2010

The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue [...]

Podcast – Translational Medicine: Evaluating its Promise, Pitfalls and Profitable Use

Wednesday, January 6th, 2010

Kevin Davies, Editor-in-Chief, Bio-IT and Tessella’s Dr Andrew Chadwick, Principle Consultant, Life Sciences and Health Care discuss Translational Medicine. Listen to this podcast and learn about: Effective, ethical approaches to trial design that harness incompletely validated predictive and prognostic biomarkers Ways to improve the value of image information and other rich data The tradeoffs to [...]